Inventor · disambiguated record
Erik Karrer
Also filed as: KARRER ERIK · KARRER ERIK E · KARRER ERIK EDWARD
14 granted patents·4 pending applications·107 citations·filing 2003–2023
92Inventor score
Top patents by PatentIndex Score
18 records- 0194US7794718B2Immunosuppressive polypeptides and nucleic acidsPERSEID THERAPEUTICS LLC·Filed 2008·Granted Sep 14, 2010·38 cites·19 claims
- 0293US8071095B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2010·Granted Dec 6, 2011·17 cites·19 claims
- 0390US8318176B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Nov 27, 2012·10 cites·8 claims
- 0490US8283447B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Oct 9, 2012·10 cites·8 claims
- 0590US8268587B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Sep 18, 2012·10 cites·48 claims
- 0687US8496935B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Jul 30, 2013·7 cites·27 claims
- 0787US8445230B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted May 21, 2013·7 cites·48 claims
- 0886US8491899B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Jul 23, 2013·6 cites·21 claims
- 0975US12351631B2Anti-CD200R1 antibodies and methods of use thereof23ANDME INC·Filed 2023·Granted Jul 8, 2025·0 cites·7 claims
- 1068US8252727B2Antibody diversity generationKARRER ERIK·Filed 2008·Granted Aug 28, 2012·2 cites·12 claims
- 1167US12304959B2Method of treating asthma with anti-IL1RAP antibodies23ANDME INC·Filed 2021·Granted May 20, 2025·0 cites·19 claims
- 1267US2024132582A1Anti-il-36 antibodies and methods of use thereof23ANDME INC·Filed 2023·Application pending·0 cites
- 1365US11787861B2Anti-CD200R1 antibodies and methods of use thereof23ANDME INC·Filed 2021·Granted Oct 17, 2023·0 cites·30 claims
- 1461US11168140B2Anti-IL1RAP antibodies23ANDME INC·Filed 2019·Granted Nov 9, 2021·0 cites·20 claims
- 1559US2005038232A1Antibody diversity generationMAXYGEN INC·Filed 2003·Application pending·0 cites
- 1656US11884719B2Anti-IL-36 antibodies and methods of use thereof23ANDME INC·Filed 2019·Granted Jan 30, 2024·0 cites·23 claims
- 1756US2025302911A1Therapeutic lipid processing compositions and methods for treating age-related macular degenerationCHARACTER BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1836US2012135912A1Polypeptide inhibitors of vla4PAIDHUNGAT MADAN M·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →